Colin C. Collins

42.4k citations

201 papers · 16.6k indexed · 7 hit papers · h-index 59

Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 33
- Cancer-related molecular mechanisms research 15
Genetics top 0.1%
- Genomic variations and chromosomal abnormalities 31
Molecular Biology top 0.2%
- Molecular Biology Techniques and Applications 21
- Genomics and Chromatin Dynamics 16
- Gene expression and cancer classification 16
Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 60
Biochemistry top 0.5%
Oncology
- Cancer-related Molecular Pathways 12

Co-authors: Joe W. Gray Richard Segraves Yuzhuo Wang David Kowbel Donna G. Albertson Stanislav Volik James C. Fuscoe Shanaz H. Dairkee
Cited by: Cancer Research Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences (4 papers)Nucleic Acids Research (4 papers)Nature Genetics (12 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Colin C. Collins

194 papers receiving 16.3k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Clinical Cancer Research
2003 Nature Genetics
1999 Nature Genetics
1998 Proceedings of the National Academy of Sciences
1998 Nature Genetics
1997 Nature Genetics
1988 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Colin C. Collins

Since Specialization

Citations

This map shows the geographic impact of Colin C. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin C. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin C. Collins more than expected).

Fields of papers citing papers by Colin C. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin C. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin C. Collins. The network helps show where Colin C. Collins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Colin C. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Colin C. Collins Line = papers co-authored together Colin C. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	scMUSCL: multi-source transfer learning for clustering scRNA-seq data Bioinformatics ·Arash Khoeini,Funda Sar,Yen‐Yi Lin,Colin C. Collins,Martin Ester	2025	0
2	Phenotype prediction from single-cell RNA-seq data using attention-based neural networks Bioinformatics ·Yuzhen Mao,Yen‐Yi Lin,Nelson K.Y. Wong,Stanislav Volik,Funda Sar,Colin C. Collins,Martin Ester	2024	8
3	RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential Molecular Cancer Research ·Benjamin Van Espen,Htoo Zarni Oo,Colin C. Collins,Ladan Fazli,Alfredo Molinolo,Kevin Y. Yip,Rabi Murad,Martin Gleave,Ze’ev A. Ronai	2023	5
4	Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer Clinical Cancer Research ·Mannan Nouri,Shabnam Massah,Josselin Caradec,Amy A. Lubik,Na Li,Sarah Truong,Ahn R. Lee,Ladan Fazli,Varune Rohan Ramnarine,Jessica M. Lovnicki,Jackson Moore,Mike Wang,Jane Foo,Martin Gleave,Brett G. Hollier,Colleen C. Nelson,Colin C. Collins,Xuesen Dong,Ralph Buttyan	2020	29
5	Identification of conserved evolutionary trajectories in tumors Bioinformatics ·Ermin Hodzic,Raunak Shrestha,Salem Malikić,Colin C. Collins,Kevin Litchfield,Samra Turajlic,S. Cenk Şahinalp	2020	9
6	AITL: Adversarial Inductive Transfer Learning with input and output space adaptation for pharmacogenomics Bioinformatics ·Hossein Sharifi-Noghabi,Shuman Peng,Olga Zolotareva,Colin C. Collins,Martin Ester	2020	37
7	Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks GigaScience ·Ermin Hodzic,Raunak Shrestha,Kaiyuan Zhu,Kuoyuan Cheng,Colin C. Collins,S. Cenk Şahinalp	2019	8
8	MOLI: multi-omics late integration with deep neural networks for drug response prediction Bioinformatics ·Hossein Sharifi-Noghabi,Olga Zolotareva,Colin C. Collins,Martin Ester	2019	248
9	MechRNA: prediction of lncRNA mechanisms from RNA–RNA and RNA–protein interactions Bioinformatics ·Alexander Gawronski,Michaël Uhl,Yajia Zhang,Yen‐Yi Lin,Yashar S. Niknafs,Varune Rohan Ramnarine,Rohit Malik,Felix Y. Feng,Arul M. Chinnaiyan,Colin C. Collins,S. Cenk Şahinalp,Rolf Backofen	2018	43
10	Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer Cancer Research ·Xinpei Ci,Jun Hao,Xin Dong,Stephen Yiu Chuen Choi,Hui Xue,Rebecca Wu,Sifeng Qu,Peter W. Gout,Fang Zhang,Anne Haegert,Ladan Fazli,Francesco Crea,Christopher J. Ong,Amina Zoubeidi,Housheng Hansen He,Martin Gleave,Colin C. Collins,Dong Lin,Yuzhuo Wang	2018	55
11	Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer Clinical Cancer Research ·Jennifer L. Kalina,David S. Neilson,Yen‐Yi Lin,Phineas T. Hamilton,Alexandra P. Comber,Emma M.H. Loy,S. Cenk Şahinalp,Colin C. Collins,Faraz Hach,Julian J. Lum	2017	17
12	Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy Clinical Cancer Research ·Himisha Beltran,Alexander W. Wyatt,Edmund C.P. Chedgy,Adam Donoghue,Matti Annala,Evan W. Warner,Kevin Beja,Michael Sigouros,Fan Mo,Ladan Fazli,Colin C. Collins,James A. Eastham,Michael J. Morris,Mary‐Ellen Taplin,Andrea Sboner,Susan Halabi,Martin Gleave	2017	52
13	Computational identification of micro-structural variations and their proteogenomic consequences in cancer Bioinformatics ·Yen-Yi Lin,Alexander Gawronski,Faraz Hach,Sujun Li,Ibrahim Numanagić,Iman Sarrafi,Swati Mishra,Andrew McPherson,Colin C. Collins,Milan Radovich,Haixu Tang,S. Cenk Şahinalp	2017	8
14	The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer Clinical Cancer Research ·Stephen Yiu Chuen Choi,Hui Xue,Rebecca Wu,Ladan Fazli,Dong Lin,Colin C. Collins,Martin Gleave,Peter W. Gout,Yuzhuo Wang	2016	79
15	BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer Clinical Cancer Research ·Iris Sze Ue Luk,Raunak Shrestha,Hui Xue,Yuwei Wang,Fang Zhang,Dong Lin,Anne Haegert,Rebecca Wu,Xin Dong,Colin C. Collins,Amina Zoubeidi,Martin Gleave,Peter W. Gout,Yuzhuo Wang	2016	25
16	Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancerbreakdown → Clinical Cancer Research ·Arun Azad,Stanislav Volik,Alexander W. Wyatt,Anne Haegert,Stéphane Le Bihan,Robert H. Bell,Shawn Anderson,Brian McConeghy,Robert Shukin,Jenny Bazov,Jack Youngren,Pamela L. Paris,George Thomas,Eric J. Small,Yuzhuo Wang,Martin Gleave,Colin C. Collins,Kim N.	2015	367
17	Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth Clinical Cancer Research ·Yoshiaki Yamamoto,Yohann Loriot,Eliana Beraldi,Fan Zhang,Alexander W. Wyatt,Nader Al Nakouzi,Fan Mo,Tianyuan Zhou,Youngsoo Kim,Brett P. Monia,A. Robert MacLeod,Ladan Fazli,Yuzhuo Wang,Colin C. Collins,Amina Zoubeidi,Martin Gleave	2015	105
18	TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair Clinical Cancer Research ·Alan Dal Pra,Emilie Lalonde,Jenna Sykes,Fiona Warde,Adrian Ishkanian,Alice Meng,Chad Maloff,John R. Srigley,Anthony M. Joshua,György Petrovics,Theodorus van der Kwast,Andrew Evans,Michael Milosevic,Fred Saad,Colin C. Collins,Jeremy A. Squire,Wan L. Lam,Tarek A. Bismar,Paul C. Boutros,Robert G. Bristow	2013	33
19	The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression Cancer Discovery ·Laurie E. Littlepage,Adam S. Adler,Hosein Kouros‐Mehr,Guiqing Huang,Jonathan Chou,Sheryl R. Krig,Obi L. Griffith,James E. Korkola,Kun Qu,Devon A. Lawson,Qing Xue,Mark D. Sternlicht,Gerrit J.P. Dijkgraaf,Paul Yaswen,Hope S. Rugo,Colleen Sweeney,Colin C. Collins,Joe W. Gray,Howard Y. Chang,Zena Werb	2012	54
20	A Group of Genome-Based Biomarkers That Add to a Kattan Nomogram for Predicting Progression in Men with High-Risk Prostate Cancer Clinical Cancer Research ·Pamela L. Paris,Vivian Weinberg,Giancarlo Albo,Ritu Roy,Catherine Burke,Jeffry Simko,Peter R. Carroll,Colin C. Collins	2009	25

About Colin C. Collins

Colin C. Collins is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 201 papers that have together received 16.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (60 papers), Cancer Genomics and Diagnostics (33 papers), Genomic variations and chromosomal abnormalities (31 papers), Molecular Biology Techniques and Applications (21 papers), Genomics and Chromatin Dynamics (16 papers), Gene expression and cancer classification (16 papers), Cancer-related molecular mechanisms research (15 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Cancer Research (4.5k citations), Genetics (4.6k citations) and Molecular Biology (10.2k citations). Colin C. Collins has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Joe W. Gray, Richard Segraves, Yuzhuo Wang, David Kowbel, Donna G. Albertson, Stanislav Volik, James C. Fuscoe, Shanaz H. Dairkee, Wen-Lin Kuo and J. E. Landegent. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact